March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...
This is the latest in a series of steps the agency has taken over the past two years to reduce reliance on animal testing. In ...
March 23, 2026 – National Institutes of Health (NIH) released the following: ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing ...
Animal testing for new drugs is being phased out because of advances made in artificial intelligence (AI), the UK’s medicines ...
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
To the editor: While only a small percentage of ALS cases are associated with the SOD1 gene mutation, the SOD1 mouse model actively contributed to the development of two key FDA-approved ALS drugs, ...